Your browser doesn't support javascript.
loading
miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease.
Fernández-Tussy, Pablo; Fernández-Ramos, David; Lopitz-Otsoa, Fernando; Simón, Jorge; Barbier-Torres, Lucía; Gomez-Santos, Beatriz; Nuñez-Garcia, Maitane; Azkargorta, Mikel; Gutiérrez-de Juan, Virginia; Serrano-Macia, Marina; Rodríguez-Agudo, Rubén; Iruzubieta, Paula; Anguita, Juan; Castro, Rui E; Champagne, Devin; Rincón, Mercedes; Elortza, Felix; Arslanow, Anita; Krawczyk, Marcin; Lammert, Frank; Kirchmeyer, Mélanie; Behrmann, Iris; Crespo, Javier; Lu, Shelly C; Mato, José M; Varela-Rey, Marta; Aspichueta, Patricia; Delgado, Teresa C; Martínez-Chantar, María L.
Afiliación
  • Fernández-Tussy P; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: pablo.fernandeztussy@yale.edu.
  • Fernández-Ramos D; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: dfernandez@cicbiogune.es.
  • Lopitz-Otsoa F; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: flopitz@cicbiogune.es.
  • Simón J; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: jsimon@cicbiogune.es.
  • Barbier-Torres L; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: Lucia.BarbierTorres@cshs.org.
  • Gomez-Santos B; Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country, 48940, Leioa, Bizkaia, Spain; Biocruces Health Research Institute, Barakaldo, Spain. Electronic address: bgomezsantos@gmail.com.
  • Nuñez-Garcia M; Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country, 48940, Leioa, Bizkaia, Spain; Biocruces Health Research Institute, Barakaldo, Spain. Electronic address: maitane.nunez@gmail.com.
  • Azkargorta M; Proteomics Platform, CIC bioGUNE, CIBERehd, ProteoRed-ISCIII, Bizkaia Science and Technology Park, Derio, 48160, Spain. Electronic address: mazkargorta@cicbiogune.es.
  • Gutiérrez-de Juan V; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: vgutierrez@cicbiogune.es.
  • Serrano-Macia M; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: mserrano@cicbiogune.es.
  • Rodríguez-Agudo R; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: rrodriguez@cicbiogune.es.
  • Iruzubieta P; Department of Gastroenterology and Hepatology, Marqués de Valdecilla University Hospital, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Infection, Immunity and Digestive Pathology Group, Research Institute Marqués de Valdecilla (IDIVAL), Santander, 39008
  • Anguita J; Macrophage and Tick Vaccine Laboratory, CIC bioGUNE, Bizkaia Science and Technology Park, Derio 48160 Bizkaia, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, 48013, Spain. Electronic address: janguita@cicbiogune.es.
  • Castro RE; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal. Electronic address: ruieduardocastro@ff.ulisboa.pt.
  • Champagne D; Department of Medicine, University of Vermont College of Medicine, Burlington, 05405, VT, USA. Electronic address: Devin.Champagne@uvm.edu.
  • Rincón M; Department of Medicine, University of Vermont College of Medicine, Burlington, 05405, VT, USA. Electronic address: Mercedes.Rincon@med.uvm.edu.
  • Elortza F; Proteomics Platform, CIC bioGUNE, CIBERehd, ProteoRed-ISCIII, Bizkaia Science and Technology Park, Derio, 48160, Spain. Electronic address: felortza@cicbiogune.es.
  • Arslanow A; Department of Medicine II, Saarland University Medical Center, 66421, Homburg, Germany. Electronic address: anita.arslanow@uks.eu.
  • Krawczyk M; Department of Medicine II, Saarland University Medical Center, 66421, Homburg, Germany. Electronic address: marcin.krawczyk@uks.eu.
  • Lammert F; Department of Medicine II, Saarland University Medical Center, 66421, Homburg, Germany. Electronic address: frank.lammert@uks.eu.
  • Kirchmeyer M; Signal Transduction Laboratory, Life Sciences Research Unit, University of Luxembourg, House of Biomedicine II, 4367, Belvaux, Luxembourg. Electronic address: kirchmeyer.melanie@gmail.com.
  • Behrmann I; Signal Transduction Laboratory, Life Sciences Research Unit, University of Luxembourg, House of Biomedicine II, 4367, Belvaux, Luxembourg. Electronic address: iris.behrmann@uni.lu.
  • Crespo J; Department of Gastroenterology and Hepatology, Marqués de Valdecilla University Hospital, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Infection, Immunity and Digestive Pathology Group, Research Institute Marqués de Valdecilla (IDIVAL), Santander, 39008
  • Lu SC; Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: Shelly.Lu@cshs.org.
  • Mato JM; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: director@cicbiogune.es.
  • Varela-Rey M; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: mvarela@cicbiogune.es.
  • Aspichueta P; Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country, 48940, Leioa, Bizkaia, Spain; Biocruces Health Research Institute, Barakaldo, Spain. Electronic address: patricia.aspichueta@ehu.es.
  • Delgado TC; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: tcardoso@cicbiogune.es.
  • Martínez-Chantar ML; Liver disease Laboratory, Liver metabolism Laboratory, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160, Derio, Bizkaia, Spain. Electronic address: mlmartinez@cicbiogune.es.
Mol Metab ; 29: 40-54, 2019 11.
Article en En | MEDLINE | ID: mdl-31668391

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: MicroARNs / Complejo II de Transporte de Electrones / Glicina N-Metiltransferasa / Enfermedad del Hígado Graso no Alcohólico Límite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Metab Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: MicroARNs / Complejo II de Transporte de Electrones / Glicina N-Metiltransferasa / Enfermedad del Hígado Graso no Alcohólico Límite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Metab Año: 2019 Tipo del documento: Article